Yu S - Search Results

1

Intra-tumour molecular heterogeneity of clear cell renal cell carcinoma reveals the diversity of the response to targeted therapies using patient-derived xenograft models.

Hong B, Yang Y, Guo S, Duoerkun S, Deng X, Chen D, Yu S, Qian W, Li Q, Li Q, Gong K, Zhang N. Hong B, et al. Among authors: yu s. Oncotarget. 2017 Jul 25;8(30):49839-49850. doi: 10.18632/oncotarget.17765. Oncotarget. 2017. PMID: 28548943 Free PMC article.

2

Aberrant overexpression of ADAR1 promotes gastric cancer progression by activating mTOR/p70S6K signaling.

Dou N, Yu S, Ye X, Yang D, Li Y, Gao Y. Dou N, et al. Among authors: yu s. Oncotarget. 2016 Dec 27;7(52):86161-86173. doi: 10.18632/oncotarget.13354. Oncotarget. 2016. PMID: 27863387 Free PMC article.

3

SRPK1 facilitates tumor cell growth via modulating the small nucleolar RNA expression in gastric cancer.

Li Y, Yu S, Wang X, Ye X, He B, Quan M, Gao Y. Li Y, et al. Among authors: yu s. J Cell Physiol. 2019 Aug;234(8):13582-13591. doi: 10.1002/jcp.28036. Epub 2019 Jan 11. J Cell Physiol. 2019. PMID: 30633341

4

SNRPA enhances tumour cell growth in gastric cancer through modulating NGF expression.

Dou N, Yang D, Yu S, Wu B, Gao Y, Li Y. Dou N, et al. Among authors: yu s. Cell Prolif. 2018 Oct;51(5):e12484. doi: 10.1111/cpr.12484. Epub 2018 Jul 24. Cell Prolif. 2018. PMID: 30039889 Free PMC article.

5

Downregulation of STRAP promotes tumor growth and metastasis in hepatocellular carcinoma via reducing PTEN level.

Wu Q, Yu S, Chen J, Li Y, Gao Y. Wu Q, et al. Among authors: yu s. IUBMB Life. 2018 Feb;70(2):120-128. doi: 10.1002/iub.1707. Epub 2017 Dec 28. IUBMB Life. 2018. PMID: 29283497 Free article.

6

Genome-scale CRISPRa screening identifies MTX1 as a contributor for sorafenib resistance in hepatocellular carcinoma by augmenting autophagy.

Li L, Yu S, Hu Q, Hai Y, Li Y. Li L, et al. Among authors: yu s. Int J Biol Sci. 2021 Jul 25;17(12):3133-3144. doi: 10.7150/ijbs.62393. eCollection 2021. Int J Biol Sci. 2021. PMID: 34421355 Free PMC article.

7

CD63 negatively regulates hepatocellular carcinoma development through suppression of inflammatory cytokine-induced STAT3 activation.

Yu S, Chen J, Quan M, Li L, Li Y, Gao Y. Yu S, et al. J Cell Mol Med. 2021 Jan;25(2):1024-1034. doi: 10.1111/jcmm.16167. Epub 2020 Dec 4. J Cell Mol Med. 2021. PMID: 33277798 Free PMC article.

8

B-cell lymphoma-2-associated transcription factor 1 is overexpressed and contributes to sorafenib resistance in hepatocellular carcinoma.

Yu S, Wang X, Dou N, Zhou J, Gao Y, Li Y. Yu S, et al. Hepatol Res. 2019 Nov;49(11):1329-1340. doi: 10.1111/hepr.13395. Epub 2019 Jul 23. Hepatol Res. 2019. PMID: 31237058

9

KLF4-Mediated CDH3 Upregulation Suppresses Human Hepatoma Cell Growth and Migration via GSK-3β Signaling.

Li L, Yu S, Wu Q, Dou N, Li Y, Gao Y. Li L, et al. Among authors: yu s. Int J Biol Sci. 2019 Mar 10;15(5):953-961. doi: 10.7150/ijbs.30857. eCollection 2019. Int J Biol Sci. 2019. PMID: 31182916 Free PMC article.

10

G3BP1 contributes to tumor metastasis via upregulation of Slug expression in hepatocellular carcinoma.

Dou N, Chen J, Yu S, Gao Y, Li Y. Dou N, et al. Among authors: yu s. Am J Cancer Res. 2016 Nov 1;6(11):2641-2650. eCollection 2016. Am J Cancer Res. 2016. PMID: 27904777 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,551 results

Search Page

Filters